Oskar Angerås
Latest contributions
Antiplatelet strategies for patients undergoing PCI
22 May 2025 – From EuroPCR 2025
Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...
Valve-in-valve TAVI
21 May 2025 – From EuroPCR 2025
Explore valve-in-valve TAVI strategies for patients with degenerated surgical valves, focusing on small aortic annuli. This session covers the impact of valve design and implant techniques, valve fracturing methods, procedural outcomes of repeat TAVI, and mid-to-long-term results from the ACCURATE NEO 2 study.
Latest generation DES - What do I need to know?
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the latest generation drug-eluting stents, such as the dynamX novolimus-eluting bioadaptor, and discover the results of various clinical trials: ANGIOLITE, DIRECT II, and more!
